Summary
The Intraperitoneal injection of CC14 leads to the disruption of hepatocyte membrane and related enzymatic reaction due to the free radical products provided by liver drug-metabolizing enzymes (1). Since cell membranes are composed of phospholipids, these reactions, occurring during liver injury, are responsible for all membrane damage. Contrarily, it has been well demonstrated (2) that hepatocytes under the regeneration cycle have a higher tolerance to stress as compared to the resting condition. Therefore, the progression of these reactions in the liver is dependent on hepatocellular regeneration and hepatolobular restoration.
By the catalyzed reaction of betaine-homocysteine methyltransferase, methyl groups are transferred from betaine to homocysteine, and also form methionine that produces further conversion to S-adenosylmethionine (SAM) (3). The synthesizing processes of methionine and SAM through the methylation of * To whom correspondence should be addressed .
homocysteine are two of the most important biochemical hepatic pathways (4) (5) (6) . Therefore, the administration of betaine would contribute to the preservation of the liver homeostasis.
In this report, we demonstrated the positive effect of betaine on acute CC14 liver injury. the mice 24h after the CCl4 injection, since the maximal peak of serum ALT activity released was observed at 24h after CCl4 treatment as reported in our previous study (11) . As shown in Fig. 1 , the levels of ALT activity released in the sera were restrained to about half of that in CCl4-treated mice, for both oral (15mg/kg body weight) and intraperitoneal (3mg/kg body weight) administration. The results of Fig. 1 suggested that the optimal concentrations of betaine under our experimental conditions are 3mg/kg body weight for intraperitoneal administration and 15mg/kg body weight for oral administration. Furthermore, oral administration (15mg/kg body weight) of betaine drastically decreases the level of liver necrosis (Table 1) and increases the incorporation of BrdU/FdU into hepatocellular nuclear DNA (Table 2) . Betaine intraperitoneally administered at 3mg/kg body weight tended to decrease liver necrosis but did not induce the uptake of S-phase indicator (Tables  1 and 2 ). 
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